Christopher G. Azzoli

Internal Medicine
593 Eddy St
Providence, RI 02903

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Molecular Characterization of Pericardial Mesothelioma With Constrictive and Recurrent Pericarditis: TAZ Amplification and Hippo Pathway.

Molecular Characterization of Pericardial Mesothelioma With Constrictive and Recurrent Pericarditis: TAZ Amplification and Hippo Pathway.

Journal: JACC. Case reports
Published: July 29, 2025

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Journal: Oncotarget
Published: March 12, 2025

Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer.

Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer.

Journal: Translational oncology
Published: March 18, 2024

Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial.

Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial.

Journal: Nature communications
Published: November 25, 2023

Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer.

Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer.

Journal: Current oncology (Toronto, Ont.)
Published: September 16, 2023

TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury.

TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury.

Journal: The Journal of clinical investigation
Published: July 07, 2023

Authors' Response to "Letter to the Editor" Submitted by S. Wang and W. Liu (re: "Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer".

Authors' Response to "Letter to the Editor" Submitted by S. Wang and W. Liu (re: "Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer".

Journal: Clinical lung cancer
Published: April 05, 2023

Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab.

Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab.

Journal: Advances in radiation oncology
Published: September 02, 2022

Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer.

Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer.

Journal: Clinical lung cancer
Published: August 17, 2022

Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study.

Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study.

Journal: ESMO open
Published: October 19, 2021

Preclinical studies with ONC201/TIC10 and lurbinectedin as a novel combination therapy in small cell lung cancer (SCLC).

Preclinical studies with ONC201/TIC10 and lurbinectedin as a novel combination therapy in small cell lung cancer (SCLC).

Journal: American journal of cancer research
Published: August 17, 2021

Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies.

Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies.

Journal: Frontiers in pharmacology
Published: July 25, 2021
Showing 1-12 of 61

Last Updated: 09/26/2026